WellPoint Reports Second Quarter 2008 Results
Second quarter 2008 net income was $750.5 million, or $1.44 per share, which included net realized investment losses of $0.03 per share. Net income in the second quarter of 2007 was $835.2 million, or $1.35 per share.
WellPoint to Cover Rotarix(R) Vaccine
Decision based on formal recommendations by the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP)
WellPoint Web Sites Receive Six World Wide Web Health Awards
Awards include Best Interactive, Most Innovative, Health Promotion/Disease & Injury Prevention Information and Medicare Part D Decision Tool for Seniors & Patient Education Information